1
|
Gamble JF, Al-Obaidi H. Past, current, and future: Application of image analysis in small molecule pharmaceutical development. J Pharm Sci 2024:S0022-3549(24)00306-X. [PMID: 39153662 DOI: 10.1016/j.xphs.2024.08.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2024] [Revised: 08/09/2024] [Accepted: 08/09/2024] [Indexed: 08/19/2024]
Abstract
The often-perceived limitations of image analysis have for many years impeded the widespread application of such systems as first line characterisation tools. Image analysis has, however, undergone a notable resurgence in the pharmaceutical industry fuelled by developments system capabilities and the desire of scientists to characterize the morphological nature of their particles more adequately. The importance of particle shape as well as size is now widely acknowledged. With the increasing use of modelling and simulations, and ongoing developments though the integration of machine learning and artificial intelligence, the utility of image analysis is increasing significantly driven by the richness of the data obtained. Such datasets provide means to circumvent the requirement to rely on less informative descriptors and enable the move towards the use of whole distributions. Combining the improved particle size and shape measurement and description with advances in modelling and simulations is enabling improved means to elucidate the link between particle and bulk powder properties. In addition to improved capabilities to describe input materials, approaches to characterize single components within multicomponent systems are providing scientists means to understand how their material may change during manufacture thus providing a means to link the behaviour of final dosage forms with the particle properties at the point of action. The aim is to provide an overview of image analysis and update readers with innovations and capabilities to other methods in the small molecule arena. We will also describe the use of AI for the improved analysis using image analysis.
Collapse
Affiliation(s)
- John F Gamble
- Bristol Myers Squibb, Reeds Lane, Moreton, Wirral, CH46 1QW, UK; Department of Pharmacy, University of Reading, Reading RG6 6AH, UK.
| | - Hisham Al-Obaidi
- Department of Pharmacy, University of Reading, Reading RG6 6AH, UK
| |
Collapse
|
2
|
Latreille PL, Pazhayattil AB, Turner S, Talwar N. A Novel image processing technique for weighted particle size distribution assessment. Drug Dev Ind Pharm 2024; 50:550-560. [PMID: 38785352 DOI: 10.1080/03639045.2024.2358366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2023] [Accepted: 05/17/2024] [Indexed: 05/25/2024]
Abstract
The objective of the study was to create a reliable method that could be used to evaluate the particle size distribution of samples and pre-mixes in real-world situations, particularly those consisting of typical formulation blends. The goal was to use this method to assess the uniformity of the samples and ensure that they met the required quality standards. The researchers aimed to create a method that could be easily incorporated into the manufacturing process, providing a practical and efficient solution. This study demonstrates the use of ImageJ software to analyze the particle size distribution (PSD) of powders. The technique produces qualitative data from microscopy images and quantitative data from analysis of parameters including average diameter, D10, D50, D90, and standard deviation. The method was tested with various treatments, showing differentiating outcomes in all cases. The alternate technique provides a rapid and cost-effective method for PSD analysis, surpassing the limitations of sieve analysis. Extensive testing of the method, using a variety of sample types, including typical formulation blends, was performed. The results suggest that the method can effectively assess the morphology of changing materials during batch manufacturing and characterize uniformity in blends. The methodology has the capability to identify attributes related to PSD that are typically required to be monitored during manufacturing. The technique allows for accurate and reliable quantification of the attributes through image capture technology. The technique has future potential and has important implications for material science, powder rheology, pharmaceutical formulation development, and continual process monitoring.
Collapse
Affiliation(s)
| | | | - Sam Turner
- Capcium Inc., Pointe-Claire, Quebec, Canada
| | | |
Collapse
|
3
|
Ur Rahman A, Nasir F, Ali Khattak M, Hidayatullah T, Pervez S, Rabqa Zainab S, Tahir Ali A, Gohar S, E Maryam G, Almalki WH. Comparative pharmacokinetic evaluation of glimepiride orodispersable and conventional tablets in rabbits. Drug Dev Ind Pharm 2024; 50:173-180. [PMID: 38265062 DOI: 10.1080/03639045.2024.2307421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Accepted: 12/20/2023] [Indexed: 01/25/2024]
Abstract
OBJECTIVES Glimepiride Orodispersable Tablets (ODT) were prepared with the goal to have rapid onset of action and higher bioavailability with ease administration to individuals with swallowing difficulty to ameliorate patient compliance. SIGNIFICANCE Glimepiride is a contemporary hypoglycemic medication that belongs to the family of sulfonylurea derivatives. It is used in type 2 diabetes mellitus. Compliance adherence remains one of the limitations with the conventional drug delivery system especially in pediatric, geriatric, psychiatric, and traveling patients, for such population ODT provides a good alternate dosage form compared with Commercial Tablets. METHOD The Comparative in vivo pharmacokinetic parameters of the prepared ODT and conventional tablets (CT) were evaluated using an animal model. The plasma concentration of Glimepiride after oral administration of a single dose was determined at predetermined time intervals with HPLC. The pharmacokinetic parameters were calculated using PK Solutions 2.0 from Summit PK® software. RESULTS The Cmax obtained with ODT (22.08 µg/ml) was significantly (p = 0.006) high, a lower tmax of 3.0 hr was achieved with the orodispersable formulation of the drug. The ODT showed 104.34% relative bioavailability as compared to CT and left shift of tmax as well. CONCLUSION As per findings of the in vivo investigation, the Glimepiride ODT would be beneficial in terms of patient compliance, quick onset of action, and increased bioavailability.
Collapse
Affiliation(s)
- Altaf Ur Rahman
- Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
| | - Fazli Nasir
- Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
| | - Muzna Ali Khattak
- Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
- Department of Pharmacy, CECOS University Peshawar, Peshawar, Pakistan
| | | | - Sadia Pervez
- Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
| | | | - Arbab Tahir Ali
- Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
| | - Shazma Gohar
- Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
| | - Gul E Maryam
- Department of Pharmacy, Qurtuba University Peshawar, Peshawar, Pakistan
| | - Waleed H Almalki
- Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah
| |
Collapse
|
4
|
Clarke J, Gamble JF, Jones JW, Tobyn M, Ingram A, Greenwood R. Determining the Impact of Roller Compaction Processing Conditions on Granulate and API Properties: Impact of Formulation API Load. AAPS PharmSciTech 2024; 25:24. [PMID: 38267745 DOI: 10.1208/s12249-024-02744-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Accepted: 01/09/2024] [Indexed: 01/26/2024] Open
Abstract
Previous work demonstrated that roller compaction of a 40%w/w theophylline-loaded formulation resulted in granulate consisting of un-compacted fractions which were shown to constitute between 34 and 48%v/v of the granulate dependent on processing conditions. The active pharmaceutical ingredient (API) primary particle size within the un-compacted fraction was also shown to have undergone notable size reduction. The aim of the current work was to test the hypothesis that the observations may be more indicative of the relative compactability of the API due to the formulation being above the percolation threshold. This was done by assessing the impact of varied API loads in the formulation on the non-granulated fraction of the final granulate and the extent of attrition of API particles within the non-granulated fraction. The influence of processing conditions for all formulations was also investigated. The results verify that the observations, both of this study and the previous work, are not a consequence of exceeding the percolation threshold. The volume of un-compacted material within the granulate samples was observed to range between 34.7 and 65.5% depending on the API load and roll pressure, whilst the API attrition was equivalent across all conditions.
Collapse
Affiliation(s)
- James Clarke
- School of Chemical Engineering, University of Birmingham, Birmingham, B15 2TT, UK
| | - John F Gamble
- Bristol Myers Squibb, Reeds Lane, Moreton, Wirral, CH46 1QW, UK.
| | - John W Jones
- Bristol Myers Squibb, Reeds Lane, Moreton, Wirral, CH46 1QW, UK
| | - Mike Tobyn
- Bristol Myers Squibb, Reeds Lane, Moreton, Wirral, CH46 1QW, UK
| | - Andrew Ingram
- School of Chemical Engineering, University of Birmingham, Birmingham, B15 2TT, UK
| | - Richard Greenwood
- School of Chemical Engineering, University of Birmingham, Birmingham, B15 2TT, UK
| |
Collapse
|
5
|
Mawla N, Alshafiee M, Gamble J, Tobyn M, Liu L, Walton K, Conway BR, Timmins P, Asare-Addo K. Comparative Evaluation of the Powder and Tableting Properties of Regular and Direct Compression Hypromellose from Different Vendors. Pharmaceutics 2023; 15:2154. [PMID: 37631368 PMCID: PMC10459357 DOI: 10.3390/pharmaceutics15082154] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Revised: 08/08/2023] [Accepted: 08/11/2023] [Indexed: 08/27/2023] Open
Abstract
Hypromellose, a widely used polymer in the pharmaceutical industry, is available in several grades, depending on the percentage of substitution of the methoxyl and hydroxypropyl groups and molecular weight, and in various functional forms (e.g., suitable for direct compression tableting). These differences can affect their physicomechanical properties, and so this study aims to characterise the particle size and mechanical properties of HPMC K100M polymer grades from four different vendors. Eight polymers (CR and DC grades) were analysed using scanning electron microscopy (SEM) and light microscopy automated image analysis particle characterisation to examine the powder's particle morphology and particle size distribution. Bulk density, tapped density, and true density of the materials were also analysed. Flow was determined using a shear cell tester. Flat-faced polymer compacts were made at five different compression forces and the mechanical properties of the compacts were evaluated to give an indication of the powder's capacity to form a tablet with desirable strength under specific pressures. The results indicated that the CR grades of the polymers displayed a smaller particle size and better mechanical properties compared to the DC grade HPMC K100M polymers. The DC grades, however, had better flow properties than their CR counterparts. The results also suggested some similarities and differences between some of the polymers from the different vendors despite the similarity in substitution level, reminding the user that care and consideration should be given when substitution is required.
Collapse
Affiliation(s)
- Nihad Mawla
- Department of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, UK; (N.M.); (M.A.); (B.R.C.)
| | - Maen Alshafiee
- Department of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, UK; (N.M.); (M.A.); (B.R.C.)
| | - John Gamble
- Drug Product Development, Bristol Myers Squibb, Moreton, Merseyside CH46 1QW, UK; (J.G.); (M.T.)
| | - Mike Tobyn
- Drug Product Development, Bristol Myers Squibb, Moreton, Merseyside CH46 1QW, UK; (J.G.); (M.T.)
| | - Lande Liu
- Department of Chemical Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK;
| | - Karl Walton
- EPSRC Future Metrology Hub, University of Huddersfield, Huddersfield HD1 3DH, UK;
| | - Barbara R. Conway
- Department of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, UK; (N.M.); (M.A.); (B.R.C.)
| | - Peter Timmins
- Department of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, UK; (N.M.); (M.A.); (B.R.C.)
| | - Kofi Asare-Addo
- Department of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, UK; (N.M.); (M.A.); (B.R.C.)
| |
Collapse
|
6
|
Gamble JF, Akseli I, Ferreira AP, Leane M, Thomas S, Tobyn M, Wadams RC. Morphological distribution mapping: Utilisation of modelling to integrate particle size and shape distributions. Int J Pharm 2023; 635:122743. [PMID: 36804520 DOI: 10.1016/j.ijpharm.2023.122743] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2022] [Revised: 02/13/2023] [Accepted: 02/14/2023] [Indexed: 02/19/2023]
Abstract
The aim of this work was to develop approaches to utilize whole particle distributions for both particle size and particle shape parameters to map the full range of particle properties in a curated dataset. It is hoped that such an approach may enable a more complete understanding of the particle landscape as a step towards improving the link between particle properties and processing behaviour. A 1-dimensional principal component analysis (PCA) approach was applied to create a 'morphological distribution landscape'. A dataset of imaged APIs, intermediates and excipients encompassing particle size, particle shape (elongation, length and width) and distribution shape was curated between 2008 and 2022. The curated dataset encompassed over 200 different materials, which included over 150 different APIs, and approximately 3500 unique samples. For the purposes of the current work, only API samples were included. The morphological landscape enables differentiation of materials of equivalent size but varying shape and vice versa. It is hoped that this type of approach can be utilised to better understand the influence of particle properties on pharmaceutical processing behaviour and thereby enable scientists to leverage historical knowledge to highlight and mitigate risks associated to materials of similar morphological nature.
Collapse
Affiliation(s)
- John F Gamble
- Bristol Myers Squibb, Reeds Lane, Moreton, Wirral CH46 1QW, UK.
| | | | - Ana P Ferreira
- Bristol Myers Squibb, Reeds Lane, Moreton, Wirral CH46 1QW, UK
| | - Michael Leane
- Bristol Myers Squibb, Reeds Lane, Moreton, Wirral CH46 1QW, UK
| | | | - Mike Tobyn
- Bristol Myers Squibb, Reeds Lane, Moreton, Wirral CH46 1QW, UK
| | | |
Collapse
|
7
|
Correlation of brittle matrix powder properties to aerodynamic performance of inhaled nintedanib made by thin-film freezing. J Drug Deliv Sci Technol 2023. [DOI: 10.1016/j.jddst.2022.104059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
8
|
Janssen PH, Jaspers M, Meier R, Roelofs TP, Dickhoff BH. The effect of excipient particle size on the reduction of compactibility after roller compaction. Int J Pharm X 2022; 4:100117. [PMID: 35496756 PMCID: PMC9043665 DOI: 10.1016/j.ijpx.2022.100117] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2022] [Revised: 04/06/2022] [Accepted: 04/12/2022] [Indexed: 12/02/2022] Open
Abstract
Developing a robust roller compaction process can be challenging, due to the diversity in process parameters and material properties of the components in a formulation. A major challenge in dry granulation is the reduction of tablet strength as a result of re-compaction of the materials. The aim of this study is to investigate the impact of excipient type and particle size distribution on tablet tensile strength after roller compaction. Lactose monohydrate, anhydrous lactose and microcrystalline cellulose with different particle sizes are roller compacted at varying specific compaction forces. Granules obtained are compressed into tablets to evaluate the reduction in tablet strength upon increasing the specific compaction force. The impact of particle size of the starting material is shown to be vastly different for the three types of excipients investigated, due to the differences in mechanical deformation mechanisms. The presence of rough surfaces and a high degree of fragmentation for anhydrous lactose appears to be beneficial for compaction and re-compaction process. Additionally, the particle size of anhydrous lactose hardly affects the tensile strength of tablets, which can be beneficial for the robustness of a roller compaction process. The impact of particle size on the re-compactibility differs per excipient type. Re-compactibility is classified and quantified for different excipients. Rough surfaces and a high degree of fragmentation are beneficial for re-compaction. The particle size of anhydrous lactose hardly affects the re-compactibility.
Collapse
Affiliation(s)
- Pauline H.M. Janssen
- DFE Pharma, Klever Strasse 187, 47568 Goch, Germany
- University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Antonius Deusinglaan 1, 9713, AV, Groningen, the Netherlands
- Corresponding author at: DFE Pharma, Klever Strasse 187, 47568 Goch, Germany.
| | | | - Robin Meier
- L.B. Bohle Maschinen und Verfahren GmbH, Industriestrasse 18, 59320 Ennigerloh, Germany
| | | | | |
Collapse
|
9
|
Frank DS, Punia A, Fahy M, Dalton C, Rowe J, Schenck L. Densifying Co-Precipitated Amorphous Dispersions to Achieve Improved Bulk Powder Properties. Pharm Res 2022; 39:3197-3208. [PMID: 36271203 DOI: 10.1007/s11095-022-03416-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2022] [Accepted: 10/11/2022] [Indexed: 12/27/2022]
Abstract
PURPOSE Precipitation of amorphous solid dispersions has gained traction in the pharmaceutical industry given its application to pharmaceuticals with varying physicochemical properties. Although preparing co-precipitated amorphous dispersions (cPAD) in high-shear rotor-stator devices allows for controlled shear conditions during precipitation, such aggressive mixing environments can result in materials with low bulk density and poor flowability. This work investigated annealing cPAD after precipitation by washing with heated anti-solvent to improve bulk powder properties required for downstream drug product processing. METHODS Co-precipitation dispersions were prepared by precipitation into pH-modified aqueous anti-solvent. Amorphous dispersions were washed with heated anti-solvent and assessed for bulk density, flowability, and dissolution behavior relative to both cPAD produced without a heated wash and spray dried intermediate. RESULTS Washing cPAD with a heated anti-solvent resulted in an improvement in flowability and increased bulk density. The mechanism of densification was ascribed to annealing over the wetted Tg of the material, which lead to collapse of the porous co-precipitate structure into densified granules without causing crystallization. In contrast, an alternative approach to increase bulk density by precipitating the ASD using low shear conditions showed evidence of crystallinity. The dissolution rate of the densified cPAD granules was lower than that of the low-bulk density dispersions, although both samples reached concentrations equivalent to that of the spray dried intermediate after 90 min dissolution. CONCLUSIONS Hot wash densification was a tenable route to produce co-precipitated amorphous dispersions with improved properties for downstream processing compared to non-densified powders.
Collapse
Affiliation(s)
- Derek S Frank
- Process Research & Development, Merck & Co., Inc., Rahway, NJ, USA.
| | - Ashish Punia
- Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, USA
| | - Mairead Fahy
- Pharmaceutical Commercialization Technology, Merck & Co., Inc., Rahway, NJ, USA
| | - Chad Dalton
- Formulation Sciences, Merck & Co., Inc., Rahway, NJ, USA
| | - Jasmine Rowe
- Formulation Sciences, Merck & Co., Inc., Rahway, NJ, USA
| | - Luke Schenck
- Process Research & Development, Merck & Co., Inc., Rahway, NJ, USA
| |
Collapse
|
10
|
Davé R, Kim S, Kunnath K, Tripathi S. A concise treatise on model-based enhancements of cohesive powder properties via dry particle coating. ADV POWDER TECHNOL 2022. [DOI: 10.1016/j.apt.2022.103836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
11
|
Timoumi A, Nguyen TC, Le T, Kraiem H, Cescut J, Anne-Archard D, Gorret N, Molina-Jouve C, To KA, Fillaudeau L. Comparison of methods to explore the morphology and granulometry of biological particles with complex shapes: Interpretation and limitations. POWDER TECHNOL 2022. [DOI: 10.1016/j.powtec.2022.118067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
12
|
Zhu A, Mao C, Luner PE, Lomeo J, So C, Marchal S, Zhang S. Investigation of Quantitative X-ray Microscopy for Assessment of API and Excipient Microstructure Evolution in Solid Dosage Processing. AAPS PharmSciTech 2022; 23:117. [PMID: 35441297 DOI: 10.1208/s12249-022-02271-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2021] [Accepted: 04/03/2022] [Indexed: 11/30/2022] Open
Abstract
Assessment and understanding of changes in particle size of active pharmaceutical ingredients (API) and excipients as a function of solid dosage form processing is an important but under-investigated area that can impact drug product quality. In this study, X-ray microscopy (XRM) was investigated as a method for determining the in situ particle size distribution of API agglomerates and an excipient at different processing stages in tablet manufacturing. An artificial intelligence (AI)-facilitated XRM image analysis tool was applied for quantitative analysis of thousands of individual particles, both of the API and the major filler component of the formulation, microcrystalline cellulose (MCC). Domain size distributions for API and MCC were generated along with the calculation of the porosity of each respective component. The API domain size distributions correlated with laser diffraction measurements and sieve analysis of the API, formulation blend, and granulation. The XRM analysis demonstrated that attrition of the API agglomerates occurred secondary to the granulation stage. These results were corroborated by particle size distribution and sieve potency data which showed generation of an API fines fraction. Additionally, changes in the XRM-calculated size distribution of MCC particles in subsequent processing steps were rationalized based on the known plastic deformation mechanism of MCC. The XRM data indicated that size distribution of the primary MCC particles, which make up the larger functional MCC agglomerates, is conserved across the stages of processing. The results indicate that XRM can be successfully applied as a direct, non-invasive method to track API and excipient particle properties and microstructure for in-process control samples and in the final solid dosage form. The XRM and AI image analysis methodology provides a data-rich way to interrogate the impact of processing stresses on API and excipients for enhanced process understanding and utilization for Quality by Design (QbD).
Collapse
|
13
|
Rosenbaum T, Mbachu V, Mitchell NA, Gamble JF, Cho P, Engstrom JD. Comparison of One-Dimensional and Two-Dimensional Population Balance Models for Optimization of a Crystallization Process for a Needle-Shaped Active Pharmaceutical Ingredient. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.1c00344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Tamar Rosenbaum
- Drug Product Science and Technology, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States
| | - Victoria Mbachu
- Drug Product Science and Technology, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States
| | - Niall Anthony Mitchell
- Process Systems Enterprise (PSE) − A Siemens Business, 6th Floor East, 26-28 Hammersmith Grove, London W6 7HA, United Kingdom
| | - John Francis Gamble
- Drug Product Science and Technology, Bristol-Myers Squibb, Moreton CH46 1QW, United Kingdom
| | - Patricia Cho
- Chemical and Synthetic Development, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States
| | - Joshua D. Engstrom
- Drug Product Science and Technology, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States
| |
Collapse
|
14
|
Meruva S, Thool P, Gong Y, Agrawal A, Karki S, Bowen W, Mitra B, Kumar S. A Novel Use of Nanocrystalline Suspensions to Develop Sub-Microgram Dose Micro-Tablets. J Pharm Sci 2021; 110:3276-3288. [PMID: 34097976 DOI: 10.1016/j.xphs.2021.05.025] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2020] [Revised: 05/21/2021] [Accepted: 05/28/2021] [Indexed: 11/24/2022]
Abstract
Developing solid oral drug products with good content uniformity (CU) at low doses is challenging; this challenge further aggravates when the tablet size decreases from a conventional tablet to a micro/mini-tablet (1.2-3 mm diameter). To alleviate the CU issues, we present a novel use of nanocrystalline suspension combined with high shear wet granulation for the first time. In this approach, nanomilled drug in the form of nanocrystalline suspension is sprayed onto the powder bed to ensure uniform distribution. The resulting granules had adequate particle size distribution and flow characteristics to enable manufacturing of micro-tablets with good weight uniformity and tensile strength. Nanomilled drug resulted in excellent content uniformity among individual micro-tablets even at a dose strength as low as 0.16 mcg, whereas micronized drug resulted in unacceptable CU even at 5x higher dose strength (0.8 mcg). Besides, the use of nanomilled drug has enhanced the dosing flexibility of micro-tablets and showed superior dissolution performance in comparison with micronized drug with no impact of storage conditions (40 °C/75%RH for six months) on their dissolution performance. The proposed approach is simple and can be easily incorporated into traditional high shear wet granulation process to develop sub-microgram dose solid oral drug products.
Collapse
Affiliation(s)
- Saikishore Meruva
- College of Pharmacy, University of Iowa, 115 S. Grand Avenue, Iowa City, IA 52242, USA
| | - Prajwal Thool
- Drug Product Development, Bristol Myers Squibb, 556 Morris Avenue, Summit, NJ 07901, USA
| | - Yuchuan Gong
- Drug Product Development, Bristol Myers Squibb, 556 Morris Avenue, Summit, NJ 07901, USA
| | - Anjali Agrawal
- Drug Product Development, Bristol Myers Squibb, 556 Morris Avenue, Summit, NJ 07901, USA
| | - Shyam Karki
- Drug Product Development, Bristol Myers Squibb, 556 Morris Avenue, Summit, NJ 07901, USA
| | - William Bowen
- Drug Product Development, Bristol Myers Squibb, 556 Morris Avenue, Summit, NJ 07901, USA
| | - Biplob Mitra
- Drug Product Development, Bristol Myers Squibb, 556 Morris Avenue, Summit, NJ 07901, USA.
| | - Sumit Kumar
- Drug Product Development, Bristol Myers Squibb, 556 Morris Avenue, Summit, NJ 07901, USA.
| |
Collapse
|
15
|
Investigation into powder tribo-charging of pharmaceuticals. Part I: Process-induced charge via twin-screw feeding. Int J Pharm 2020; 591:120014. [PMID: 33122114 DOI: 10.1016/j.ijpharm.2020.120014] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2020] [Revised: 10/19/2020] [Accepted: 10/20/2020] [Indexed: 11/23/2022]
Abstract
Powder feeding is a crucial unit operation in continuous manufacturing (CM) of pharmaceutical products. Twin-screw feeders are typically employed to ensure the accurate mass flow of pharmaceutical materials throughout the production process. Here, contact and separation of particles can give rise to electrostatic charges, affecting feeder performance and final product quality. The knowledge of the material charging tendency would therefore be beneficial for both formulation and process design. At the early stage of product development, only a limited amount of material is available and the propensity of the powders to charge needs to be assessed on lab test equipment, which not necessarily represent the material state during processing. In this study, the tribo-charging behaviour of a set of common pharmaceutical materials (i.e., microcrystalline cellulose, D-mannitol, paracetamol and magnesium stearate) was experimentally evaluated. To this end, powder materials were let to flow over the stainless-steel pipes of the GranuCharge™ instrument. The resulting charge was compared to the one acquired during twin-screw feeding. In both cases, paracetamol exhibited the highest charging tendency followed by D-mannitol and microcrystalline cellulose and last by magnesium stearate. A good correlation was found for charge values obtained for both methods, despite the different tribo-charging mechanisms involved in the two set-ups. However, these differences in experimental set-ups led to diverse magnitudes and, in one case, polarity of charge. Additionally, an extensive material characterization was performed on the selected powders and results were statistically analyzed to identify critical material attributes (CMAs) affecting powder tribo-charging. A strong correlation was obtained between the measured charge and inter-particle friction. This indicated the latter as one of the most influencing material characteristic impacting the powder tribo-charging phenomenon of the selected materials.
Collapse
|
16
|
Clarke J, Gamble JF, Jones JW, Tobyn M, Dawson N, Davies C, Ingram A, Greenwood R. Determining the Impact of Roller Compaction Processing Conditions on Granule and API Properties. AAPS PharmSciTech 2020; 21:218. [PMID: 32743765 DOI: 10.1208/s12249-020-01773-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2020] [Accepted: 07/22/2020] [Indexed: 01/08/2023] Open
Abstract
The attrition of drug particles during the process of dry granulation, which may (or may not) be incorporated into granules, could be an important factor in determining the subsequent performance of that granulation, including key factors such as sticking to punches and bio-performance of the dosage form. It has previously been demonstrated that such attrition occurs in one common dry granulation process train; however, the fate of these comminuted particles in granules was not determined. An understanding of the phenomena of attrition and incorporation into granule will improve our ability to understand the performance of granulated systems, ultimately leading to an improvement in our ability to optimize and model the process. Unique feeding mechanisms, geometry, and milling systems of roller compaction equipment mean that attrition could be more or less substantial for any given equipment train. In this work, we examined attrition of API particles and their incorporation into granule in an equipment train from Gerteis, a commonly used equipment train for dry granulation. The results demonstrate that comminuted drug particles can exist free in post-milling blends of roller compaction equipment trains. This information can help better understand the performance of the granulations, and be incorporated into mechanistic models to optimize such processes.
Collapse
|
17
|
Demonstration of the Feasibility of Predicting the Flow of Pharmaceutically Relevant Powders from Particle and Bulk Physical Properties. J Pharm Innov 2020. [DOI: 10.1007/s12247-020-09433-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
|
18
|
A Proposal for an Alternative Approach to Particle Size Method Development During Early-Stage Small Molecule Pharmaceutical Development. J Pharm Sci 2019; 108:3515-3520. [DOI: 10.1016/j.xphs.2019.08.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2019] [Revised: 08/07/2019] [Accepted: 08/19/2019] [Indexed: 12/29/2022]
|
19
|
El-Laithy HM, Badawi A, Abdelmalak NS, Elsayyad NME. Stabilizing excipients for engineered clopidogrel bisulfate procubosome derived in situ cubosomes for enhanced intestinal dissolution: Stability and bioavailability considerations. Eur J Pharm Sci 2019; 136:104954. [DOI: 10.1016/j.ejps.2019.06.008] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2019] [Revised: 06/04/2019] [Accepted: 06/05/2019] [Indexed: 12/29/2022]
|
20
|
Browne E, Charifou R, Worku ZA, Babu RP, Healy AM. Amorphous solid dispersions of ketoprofen and poly-vinyl polymers prepared via electrospraying and spray drying: A comparison of particle characteristics and performance. Int J Pharm 2019; 566:173-184. [DOI: 10.1016/j.ijpharm.2019.05.062] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2019] [Revised: 05/22/2019] [Accepted: 05/23/2019] [Indexed: 11/25/2022]
|
21
|
Alternative approach for defining the particle population requirements for static image analysis based particle characterization methods. ADV POWDER TECHNOL 2019. [DOI: 10.1016/j.apt.2019.02.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
|
22
|
Predicting the Angle of Internal Friction from Simple Dynamic Consolidation Using Lactose Grades as Model. J Pharm Innov 2019. [DOI: 10.1007/s12247-019-09387-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
23
|
Ferreira AP, Gamble JF, Leane MM, Park H, Olusanmi D, Tobyn M. Enhanced Understanding of Pharmaceutical Materials Through Advanced Characterisation and Analysis. AAPS PharmSciTech 2018; 19:3462-3480. [PMID: 30411240 DOI: 10.1208/s12249-018-1198-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2018] [Accepted: 09/26/2018] [Indexed: 11/30/2022] Open
Abstract
The impact of pharmaceutical materials properties on drug product quality and manufacturability is well recognised by the industry. An ongoing effort across industry and academia, the Manufacturing Classification System consortium, aims to gather the existing body of knowledge in a common framework to provide guidance on selection of appropriate manufacturing technologies for a given drug and/or guide optimization of the physical properties of the drug to facilitate manufacturing requirements for a given processing route. Simultaneously, material scientists endeavour to develop characterisation methods such as size, shape, surface area, density, flow and compactibility that enable a stronger understanding of materials powder properties. These properties are routinely tested drug product development and advances in instrumentation and computing power have enabled novel characterisation methods which generate larger, more complex data sets leading to a better understanding of the materials. These methods have specific requirements in terms of data management and analysis. An appropriate data management strategy eliminates time-consuming data collation steps and enables access to data collected for multiple methods and materials simultaneously. Methods ideally suited to extract information from large, complex data sets such as multivariate projection methods allow simpler representation of the variability contained within the data and easier interpretation of the key information it contains. In this review, an overview of the current knowledge and challenges introduced by modern pharmaceutical material characterisation methods is provided. Two case studies illustrate how the incorporation of multivariate analysis into the material sciences workflow facilitates a better understanding of materials.
Collapse
|
24
|
Xiao F, Miao Q, Wei S, Liang W, Fan X, Pan K, Xu L. Hydrothermal synthesis of nanoplates assembled hierarchical h-WO3 microspheres and phase evolution in preparing cubic Zr(Y)O2-doped tungsten powders. ADV POWDER TECHNOL 2018. [DOI: 10.1016/j.apt.2018.07.011] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
25
|
Yang B, Wei C, Yang Y, Wang Q, Li S. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration. Drug Dev Ind Pharm 2018; 44:1417-1425. [DOI: 10.1080/03639045.2018.1453519] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
- Baixue Yang
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning, PR China
| | - Chen Wei
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning, PR China
| | - Yang Yang
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning, PR China
| | - Qifang Wang
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning, PR China
| | - Sanming Li
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning, PR China
| |
Collapse
|
26
|
|
27
|
Khlibsuwan R, Pongjanyakul T. Particle agglomeration of chitosan-magnesium aluminum silicate nanocomposites for direct compression tablets. Int J Pharm 2017; 535:410-419. [PMID: 29155229 DOI: 10.1016/j.ijpharm.2017.11.030] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2017] [Revised: 11/08/2017] [Accepted: 11/14/2017] [Indexed: 10/18/2022]
Abstract
Exfoliated nanocomposites of chitosan-magnesium aluminum silicate (CS-MAS) particles are characterized by good compressibility but poor flowability. Thus, the aims of this study were to investigate agglomerates of CS-MAS nanocomposites prepared using the agglomerating agents water, ethanol, or polyvinylpyrrolidone (PVP) for flowability enhancement and to evaluate the agglomerates obtained as direct compression fillers for tablets. The results showed that the addition of agglomerating agents did not affect crystallinity, but slightly influenced thermal behavior of the CS-MAS nanocomposites. The agglomerates prepared using water were larger than those prepared using 95% ethanol because high swelling of the layer of chitosonium acetate occurred, allowing formation of solid bridges and capillary force between particles, leading to higher flowability and particle strength. Incorporation of PVP resulted in larger agglomerates with good flowability and high strength due to the binder hardening mechanism. The tablets prepared from agglomerates using water showed lower hardness, shorter disintegration times and faster drug release than those using 95% ethanol. In contrast, greater hardness and more prolonged drug release were obtained from the tablets prepared from agglomerates using PVP. Additionally, the agglomerates of CS-MAS nanocomposites showed good carrying capacity and provided desirable characteristics of direct compression tablets.
Collapse
Affiliation(s)
- Rapee Khlibsuwan
- Division of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand
| | - Thaned Pongjanyakul
- Division of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.
| |
Collapse
|
28
|
Fang L, Yin X, Wu L, He Y, He Y, Qin W, Meng F, York P, Xu X, Zhang J. Classification of microcrystalline celluloses via structures of individual particles measured by synchrotron radiation X-ray micro-computed tomography. Int J Pharm 2017; 531:658-667. [DOI: 10.1016/j.ijpharm.2017.05.019] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2017] [Revised: 05/03/2017] [Accepted: 05/09/2017] [Indexed: 11/29/2022]
|
29
|
Study on the flow properties of Ti-6Al-4V powders prepared by radio-frequency plasma spheroidization. ADV POWDER TECHNOL 2017. [DOI: 10.1016/j.apt.2017.06.025] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
30
|
Nsor-Atindana J, Chen M, Goff HD, Zhong F, Sharif HR, Li Y. Functionality and nutritional aspects of microcrystalline cellulose in food. Carbohydr Polym 2017; 172:159-174. [PMID: 28606522 DOI: 10.1016/j.carbpol.2017.04.021] [Citation(s) in RCA: 104] [Impact Index Per Article: 14.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2016] [Revised: 03/21/2017] [Accepted: 04/09/2017] [Indexed: 01/14/2023]
Abstract
Microcrystalline cellulose (MCC) is among the most commonly used cellulose derivatives in the food industry. In order assess the recent advances of MCC in food product development and its associated nutraceutical implications, google scholar and database of journals subscribed by Jiangnan university, China were used to source literature. Recently published research articles that reported physicochemical properties of MCC for food application or potential application in food and nutraceutical functions were reviewed and major findings outlined. The selected literature reviewed demonstrated that the material has been extensively explored as a functional ingredient in food including meat products, emulsions, beverages, dairy products, bakery, confectionary and filling. The carbohydrate polymer also has many promising applications in functional and nutraceutical food industries. Though widely used as control for many dietary fiber investigations, MCC has been shown to provide positive effects on gastrointestinal physiology, and hypolipidemic effects, influencing the expression of enzymes involved in lipid metabolism. These techno-functional and nutraceutical properties of MCC are influenced by the physicochemical of the material, which are defined by the raw material source and processing conditions. Apart from these functional properties, this review also highlighted limitations and gaps regarding the application of material in food and nutritional realms. Functional, Nutritional and health claims of MCC.
Collapse
Affiliation(s)
- John Nsor-Atindana
- State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, 214122 Wuxi, Jiangsu Province, China; Department of Nutrition and Dietetics, University of Health Allied Sciences, Ho, Ghana
| | - Maoshen Chen
- State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, 214122 Wuxi, Jiangsu Province, China
| | - H Douglas Goff
- Department of Food Science, University of Guelph, Canada
| | - Fang Zhong
- State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, 214122 Wuxi, Jiangsu Province, China.
| | - Hafiz Rizwan Sharif
- State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, 214122 Wuxi, Jiangsu Province, China
| | - Yue Li
- State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, 214122 Wuxi, Jiangsu Province, China
| |
Collapse
|
31
|
Influence of particle properties on powder bulk behaviour and processability. Int J Pharm 2017; 518:138-154. [DOI: 10.1016/j.ijpharm.2016.12.045] [Citation(s) in RCA: 49] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2016] [Revised: 12/16/2016] [Accepted: 12/19/2016] [Indexed: 11/18/2022]
|
32
|
Ferreira AP, Olusanmi D, Sprockel O, Abebe A, Nikfar F, Tobyn M. Use of similarity scoring in the development of oral solid dosage forms. Int J Pharm 2016; 514:335-340. [PMID: 26423176 DOI: 10.1016/j.ijpharm.2015.09.046] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2015] [Revised: 09/18/2015] [Accepted: 09/19/2015] [Indexed: 11/27/2022]
Abstract
In the oral solid dosage form space, material physical properties have a strong impact on the behaviour of the formulation during processing. The ability to identify materials with similar characteristics (and thus expected to exhibit similar behaviour) within the company's portfolio can help accelerate drug development by enabling early assessment and prediction of potential challenges associated with the powder properties of a new active pharmaceutical ingredient. Such developments will aid the production of robust dosage forms, in an efficient manner. Similarity scoring metrics are widely used in a number of scientific fields. This study proposes a practical implementation of this methodology within pharmaceutical development. The developed similarity metrics is based on the Mahalanobis distance. Scanning electron microscopy was used to confirm morphological similarity between the reference material and the closest matches identified by the metrics proposed. The results show that the metrics proposed are able to successfully identify material with similar physical properties.
Collapse
Affiliation(s)
- Ana P Ferreira
- Drug Product Science & Technology, Bristol-Myers Squibb, Reeds Lane, Moreton, Wirral, CH46 1QW, UK.
| | - Dolapo Olusanmi
- Drug Product Science & Technology, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick NJ08903, USA
| | - Omar Sprockel
- Drug Product Science & Technology, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick NJ08903, USA
| | - Admassu Abebe
- Drug Product Science & Technology, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick NJ08903, USA
| | - Faranak Nikfar
- Drug Product Science & Technology, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick NJ08903, USA
| | - Mike Tobyn
- Drug Product Science & Technology, Bristol-Myers Squibb, Reeds Lane, Moreton, Wirral, CH46 1QW, UK
| |
Collapse
|
33
|
Narang AS, Stevens T, Hubert M, Paruchuri S, Macias K, Bindra D, Gao Z, Badawy S. Resolution and Sensitivity of Inline Focused Beam Reflectance Measurement During Wet Granulation in Pharmaceutically Relevant Particle Size Ranges. J Pharm Sci 2016; 105:3594-3602. [PMID: 27745886 DOI: 10.1016/j.xphs.2016.09.001] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2016] [Revised: 08/22/2016] [Accepted: 09/01/2016] [Indexed: 11/18/2022]
Abstract
Real-time process monitoring using a process analytical technology for granule size distribution can enable quality-by-design in drug product manufacturing. In this study, the resolution and sensitivity of chord length distribution (CLD) measured inline inside a high shear granulator using focused beam reflectance measurement (FBRM) C35 probe was investigated using different particle size grades of microcrystalline cellulose (MCC). In addition, the impact of water and impeller tip speed on the measurement accuracy as well as correlation with offline particle sizing techniques (FBRM, laser diffraction [Malvern Mastersizer®], microscopy [Sympatec QicPic®], and nested sieve analysis) was studied. Inline FBRM resolved size differences between different MCC grades, and the data correlated well with offline analyses. Impeller tip speed changed the number density of inline CLD measurements while addition of water reduced the CLD of dry MCC, likely due to deagglomeration of primary particles. In summary, inline FBRM CLD measurement in high shear granulator provides adequate resolution and reproducible measurements in the pharmaceutically relevant size range both in the presence and in the absence of water. Therefore, inline FBRM can be a valuable tool for the monitoring of high shear wet granulation.
Collapse
Affiliation(s)
- Ajit S Narang
- Drug Product Science & Technology, Bristol-Myers Squibb Company, One Squibb Dr., New Brunswick, New Jersey 08903.
| | - Timothy Stevens
- Analytical and Bioanalytical Development, Bristol-Myers Squibb Company, One Squibb Dr., New Brunswick, New Jersey 08903
| | - Mario Hubert
- Analytical and Bioanalytical Development, Bristol-Myers Squibb Company, One Squibb Dr., New Brunswick, New Jersey 08903
| | - Srinivasa Paruchuri
- Drug Product Science & Technology, Bristol-Myers Squibb Company, One Squibb Dr., New Brunswick, New Jersey 08903
| | - Kevin Macias
- Analytical and Bioanalytical Development, Bristol-Myers Squibb Company, One Squibb Dr., New Brunswick, New Jersey 08903
| | - Dilbir Bindra
- Drug Product Science & Technology, Bristol-Myers Squibb Company, One Squibb Dr., New Brunswick, New Jersey 08903
| | - Zhihui Gao
- Drug Product Science & Technology, Bristol-Myers Squibb Company, One Squibb Dr., New Brunswick, New Jersey 08903
| | - Sherif Badawy
- Drug Product Science & Technology, Bristol-Myers Squibb Company, One Squibb Dr., New Brunswick, New Jersey 08903
| |
Collapse
|
34
|
Gamble JF, Dennis AB, Hutchins P, Jones JW, Musembi P, Tobyn M. Determination of process variables affecting drug particle attrition within multi-component blends during powder feed transmission. Pharm Dev Technol 2016; 22:904-909. [DOI: 10.1080/10837450.2016.1200616] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- John F. Gamble
- Drug Product Science & Technology, Bristol-Myers Squibb, Moreton, Wirral, UK
| | - Andrew B. Dennis
- Drug Product Science & Technology, Bristol-Myers Squibb, Moreton, Wirral, UK
| | - Paul Hutchins
- Drug Product Science & Technology, Bristol-Myers Squibb, Moreton, Wirral, UK
| | - John W. Jones
- Drug Product Science & Technology, Bristol-Myers Squibb, Moreton, Wirral, UK
| | - Pauline Musembi
- School of Chemistry, Cardiff University, Park Place, Cardiff, UK
| | - Mike Tobyn
- Drug Product Science & Technology, Bristol-Myers Squibb, Moreton, Wirral, UK
| |
Collapse
|
35
|
Wang Z, Shah UV, Olusanmi D, Narang AS, Hussain MA, Gamble JF, Tobyn MJ, Heng JYY. Measuring the sticking of mefenamic acid powders on stainless steel surface. Int J Pharm 2015; 496:407-13. [PMID: 26456293 DOI: 10.1016/j.ijpharm.2015.09.067] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2015] [Revised: 09/28/2015] [Accepted: 09/30/2015] [Indexed: 10/22/2022]
Abstract
This study proposes an approach for quantifying the amount of pharmaceutical powder adhering (quality attribute) to the metals surfaces. The effect of surface roughness (detrimental attribute) on the amount of powder sticking to a stainless steel surface for a model pharmaceutical material is also qualitatively determined. Methodology to quantify powder adhesion to surfaces utilises a texture analyser and HPLC. The approach was validated to qualitatively investigate effect of metal surface roughness on adhesion of mefenamic acid. An increase in metal surface roughness resulted in an increase in cohesion. By increasing the average roughness from 289nm to 407nm, a 2.5 fold increase in amount adhering to metal was observed, highlighting the role of surface roughness on adhesion. The simplicity in experimental design with no requirement of specialised equipment and operational ease makes the approach very easy to adopt. Further, ease in interpreting results makes this methodology very attractive.
Collapse
Affiliation(s)
- Zihua Wang
- Surfaces and Particle Engineering Laboratory (SPEL), Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK(1)
| | - Umang V Shah
- Surfaces and Particle Engineering Laboratory (SPEL), Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK(1)
| | - Dolapo Olusanmi
- Bristol-Myers Squibb, Co., One Squibb Drive, New Brunswick, NJ 08902, USA
| | - Ajit S Narang
- Bristol-Myers Squibb, Co., One Squibb Drive, New Brunswick, NJ 08902, USA
| | - Munir A Hussain
- Bristol-Myers Squibb, Co., One Squibb Drive, New Brunswick, NJ 08902, USA
| | - John F Gamble
- Bristol-Myers Squibb Pharmaceuticals, Reeds Lane, Moreton, Wirral CH46 1QW, UK
| | - Michael J Tobyn
- Bristol-Myers Squibb Pharmaceuticals, Reeds Lane, Moreton, Wirral CH46 1QW, UK
| | - Jerry Y Y Heng
- Surfaces and Particle Engineering Laboratory (SPEL), Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK(1).
| |
Collapse
|
36
|
Hoffmann M, Wray PS, Gamble JF, Tobyn M. Investigation into process-induced de-aggregation of cohesive micronised API particles. Int J Pharm 2015; 493:341-6. [DOI: 10.1016/j.ijpharm.2015.07.073] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2015] [Revised: 07/23/2015] [Accepted: 07/28/2015] [Indexed: 11/29/2022]
|
37
|
Understanding the impact of microcrystalline cellulose physicochemical properties on tabletability. Int J Pharm 2015; 490:47-54. [DOI: 10.1016/j.ijpharm.2015.05.026] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2015] [Revised: 05/07/2015] [Accepted: 05/09/2015] [Indexed: 11/22/2022]
|
38
|
Gamble JF, Tobyn M, Hamey R. Application of Image-Based Particle Size and Shape Characterization Systems in the Development of Small Molecule Pharmaceuticals. J Pharm Sci 2015; 104:1563-74. [DOI: 10.1002/jps.24382] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2014] [Revised: 01/15/2015] [Accepted: 01/20/2015] [Indexed: 11/12/2022]
|
39
|
Hughes H, Leane MM, Tobyn M, Gamble JF, Munoz S, Musembi P. Development of a material sparing bulk density test comparable to a standard USP method for use in early development of API's. AAPS PharmSciTech 2015; 16:165-70. [PMID: 25233802 DOI: 10.1208/s12249-014-0215-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2014] [Accepted: 08/25/2014] [Indexed: 11/30/2022] Open
Abstract
Bulk density can be a key indicator of performance, and may influence choice of formulation route of materials in pharmaceutical development. During early development, the cost of API's can be expensive and the availability of material for powder property analysis is limited. The aim of this work was to investigate a suitable small-scale, low material requirement, bulk density test which would provide comparable data to the recommended large volume USP test. Materials with a range of morphological characteristics typically seen in the pharmaceutical industry were assessed to ensure that methods were suitably robust. It was found that the USP II "low volume" test does not give equivalent results to other tests in the USP, across the range of materials. An alternative test based on the FT4 powder rheometer at a scale of 25 mL gave results equivalent to the large volume USP I standard test. The use of smaller 10-mL methods was also found to give acceptable results for materials that were considered well-behaved but were more variable with difficult to handle materials with low bulk density.
Collapse
|
40
|
Impact of microcrystalline cellulose material attributes: a case study on continuous twin screw granulation. Int J Pharm 2014; 478:705-17. [PMID: 25479098 DOI: 10.1016/j.ijpharm.2014.11.070] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2014] [Revised: 11/27/2014] [Accepted: 11/29/2014] [Indexed: 11/20/2022]
Abstract
The International Conference on Harmonisation (ICH) states in its Q8 'Pharmaceutical Development' guideline that the manufacturer of pharmaceuticals should have an enhanced knowledge of the product performance over a range of material attributes, manufacturing process options and process parameters. The present case study evaluates the effect of unspecified variability of raw material properties upon the quality attributes of granules; produced using a continuous from-powder-to-tablet wet granulation line (ConsiGma™ 25). The impact of different material attributes of six samples of microcrystalline cellulose (MCC) was investigated. During a blind study the different samples of MCC were used separately and the resulting granules were evaluated in order to identify the differences between the six samples. Variation in size distribution due to varying water binding capacity of the MCC samples was observed. The cause of this different water binding capacity was investigated and was caused by a different degree of crystallinity. Afterwards, an experimental design was conducted in order to evaluate the effect of both product and process variability upon the granule size distribution. This model was used in order to calculate the required process parameters to obtain a preset granule size distribution regardless of the type of MCC used. The difference in water binding capacity and its effect on granular properties was still present when combining the MCC grades with different binders.
Collapse
|
41
|
Thoorens G, Krier F, Leclercq B, Carlin B, Evrard B. Microcrystalline cellulose, a direct compression binder in a quality by design environment—A review. Int J Pharm 2014; 473:64-72. [DOI: 10.1016/j.ijpharm.2014.06.055] [Citation(s) in RCA: 231] [Impact Index Per Article: 23.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2014] [Revised: 06/22/2014] [Accepted: 06/27/2014] [Indexed: 10/25/2022]
|
42
|
Effect of particle shape on powder flowability of microcrystalline cellulose as determined using the vibration shear tube method. Int J Pharm 2014; 473:572-8. [DOI: 10.1016/j.ijpharm.2014.07.040] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2014] [Revised: 05/11/2014] [Accepted: 07/25/2014] [Indexed: 11/19/2022]
|
43
|
Shah UV, Olusanmi D, Narang AS, Hussain MA, Gamble JF, Tobyn MJ, Heng JY. Effect of crystal habits on the surface energy and cohesion of crystalline powders. Int J Pharm 2014; 472:140-7. [DOI: 10.1016/j.ijpharm.2014.06.014] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2014] [Revised: 06/03/2014] [Accepted: 06/07/2014] [Indexed: 10/25/2022]
|
44
|
Mechanisms of crack formation in die compacted powders during unloading and ejection: An experimental and modeling comparison between standard straight and tapered dies. POWDER TECHNOL 2014. [DOI: 10.1016/j.powtec.2014.04.086] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
45
|
Gamble JF, Hoffmann M, Hughes H, Hutchins P, Tobyn M. Monitoring process induced attrition of drug substance particles within formulated blends. Int J Pharm 2014; 470:77-87. [DOI: 10.1016/j.ijpharm.2014.04.028] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2014] [Revised: 04/10/2014] [Accepted: 04/12/2014] [Indexed: 11/25/2022]
|
46
|
Decoupling the Contribution of Surface Energy and Surface Area on the Cohesion of Pharmaceutical Powders. Pharm Res 2014; 32:248-59. [DOI: 10.1007/s11095-014-1459-3] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2014] [Accepted: 07/02/2014] [Indexed: 11/28/2022]
|
47
|
Population balance modelling and multi-stage optimal control of a pulsed spray fluidized bed granulation. Int J Pharm 2014; 468:223-33. [PMID: 24732033 DOI: 10.1016/j.ijpharm.2014.04.024] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2014] [Revised: 04/08/2014] [Accepted: 04/08/2014] [Indexed: 11/23/2022]
Abstract
In this work, one-dimensional population balance models (PBMs) have been developed to model a pulsed top-spray fluidized bed granulation. The developed PBMs have linked the key binder solution spray operating factors of the binder spray rate, atomizing air pressure and pulsed frequency of spray with the granule properties to predict granule growth behaviour in the pulsed spray fluidized bed granulation process at different operating conditions with accuracy. A multi-stage open optimal control strategy based on the developed PBMs was proposed to reduce the model mismatch, in which through adjusting the trajectory of the evolution of the granule size distribution at predefined sample intervals, to determine the optimal operating variables related to the binder spray including the spray rate of binding liquid, atomizing air pressure and pulsed frequency of spray. The effectiveness of the proposed modelling and multi-stage open optimal control strategies has been validated by experimental and simulation tests.
Collapse
|
48
|
Application of imaging based tools for the characterisation of hollow spray dried amorphous dispersion particles. Int J Pharm 2014; 465:210-7. [DOI: 10.1016/j.ijpharm.2014.02.002] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2013] [Revised: 01/28/2014] [Accepted: 02/01/2014] [Indexed: 11/22/2022]
|
49
|
Osei-Yeboah F, Feng Y, Sun CC. Evolution of structure and properties of granules containing microcrystalline cellulose and polyvinylpyrrolidone during high-shear wet granulation. J Pharm Sci 2013; 103:207-15. [PMID: 24218097 DOI: 10.1002/jps.23776] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2013] [Revised: 10/12/2013] [Accepted: 10/14/2013] [Indexed: 11/07/2022]
Abstract
Granulation behavior of microcrystalline cellulose (MCC) in the presence of 2.5% polyvinylpyrrolidone (PVP) was systematically studied. Complex changes in flowability and tabletability of lubricated MCC granules are correlated to changes in intragranular porosity, morphology, surface smoothness, size distribution, and specific surface area (SSA). With 2.5% PVP, the use of 45% granulation water leads to 84% reduction in tablet tensile strength and 76% improvement in powder flow factor. The changes in powder performance are explained by granule densification and surface smoothing. The granulating water level corresponding to the onset of overgranulation, 45%, is significantly lower than the 70% water required for unlubricated MCC granules without PVP. At more than 45% water levels, MCC-PVP granules flow well but cannot be compressed into intact tablets. Such changes in powder performance correspond to the rapid growth into large and dense spheres with smooth surface. Compared with MCC alone, the onset of the phase of fast granule size enlargement occurs at a lower water level when 2.5% PVP is used. Although the use of 2.5% PVP hastens granule nucleation and growth rate, the mechanisms of overgranulation are the same, that is, size enlargement, granule densification, surface smoothing, and particle rounding in both systems.
Collapse
Affiliation(s)
- Frederick Osei-Yeboah
- Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, 55455
| | | | | |
Collapse
|
50
|
Mastropietro DJ, Omidian H. Prevalence and trends of cellulosics in pharmaceutical dosage forms. Drug Dev Ind Pharm 2012; 39:382-92. [DOI: 10.3109/03639045.2012.683874] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|